Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.55 USD | -0.18% | +0.22% | +8.55% |
16/05 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
30/04 | Axonics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Medical Devices & Implants
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
3.45B | - | |||||
127B | ||||||
11.32B | ||||||
9.04B | ||||||
5.56B | - | |||||
4.72B |
- Stock Market
- Equities
- AXNX Stock
- Charts Axonics, Inc.
- Sector Chart